Status:
RECRUITING
The BRIDGE Study - Bronchiectasis Research Involving Databases, Genomics and Endotyping
Lead Sponsor:
University of Dundee
Conditions:
Bronchiectasis Adult
Eligibility:
All Genders
18+ years
Brief Summary
Bronchiectasis is a complex heterogeneous disorder. Treatment is challenging and many recent randomized controlled trials have been negative. It is believed that bronchiectasis as a broad diagnosis in...
Detailed Description
Background: Bronchiectasis is a common disabling and heterogeneous disease that has been neglected in terms of basic and clinical research. Recent controlled trials have failed to achieve their primar...
Eligibility Criteria
Inclusion
- A previous CT scan showing bronchiectasis along with compatible clinical syndrome of cough, sputum production and/or recurrent respiratory tract infections.
- A primary diagnosis of bronchiectasis made by a respiratory physician
- At the screening visit the individual will have been clinically stable for 4 weeks indicated by the lack of any treatment with antibiotics or corticosteroids for a pulmonary exacerbation in the previous 4 weeks.
Exclusion
- Inability to give informed consent
- \<18years of age
- Patients with active tuberculosis
- Treatment with antibiotics or corticosteroids for a pulmonary exacerbation in the previous 4 weeks
- Bronchiectasis due to cystic fibrosis
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03791086
Start Date
November 1 2019
End Date
February 1 2027
Last Update
March 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Dundee
Dundee, United Kingdom, DD1 9SY